Prioritised investments from pharma companies shaping competitive pipeline landscape of bronchiectasis: GlobalData Read more
Asthma inhaler price cap in US may help pharma companies to secure more loyal customer base: GlobalData Read more
Boehringer’s Cyltezo illustrates intersection of price and regulation in biosimilar market: GlobalData Read more
Boehringer Ingelheim receives ad-interim injunctions against four more domestic pharma companies for patent infringement of its anti-diabetes drug Read more